Skip to main content
OpenTrials
Completed

NCT Number: NCT00824226

Magnesium Treatment in Hypoparathyroidism

Study hypothesis: supplementary magnesium may influence the blood calcium level in treated hypoparathyroid patients. Patients will be treated with supplementary magnesium (350 mg/day) for 3 weeks. Calcium and other relevant blood parameters will be measured before the treatment, at the end of treatment and 2 weeks after stopping treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypoparathyroidism Endocrine System Diseases Parathyroid Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tartu University Hospital

Tartu, 50406, Estonia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary or secondary hypoparathyroidism
  • treatment with calcium plus vitamin D analogue
  • ionized calcium 1,0-1,29 mmol/L
  • magnesium level 0,7-1,05 mmol/L
  • TSH 0.1- 10 imU/L

Exclusion criteria

  • any other disease known to influence plasma Ca level
  • pregnancy
  • creatinine > 150 microM/L
  • patient has used supplementary magnesium within 2 previous months

Treatment and study plan

magnesium

Dietary Supplement

magnesium 350 mg tablets once a day for 3 weeks

Primary outcomes

  1. Calcium level at the end of magnesium treatment compared to pretreatment level

    Time frame: 3 weeks

Secondary outcomes

  1. Calcium level after stopping treatment compared to the level at the end of magnesium treatment

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

University of Tartu

Other

Registry information

Official study title

Effect of Magnesium Treatment on Plasma Calcium in Hypoparathyroid Patients

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jan 16, 2009
Registry last updated
Aug 29, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.